Select a Size
| Size/SKU | Availability | Price |
|---|
About This Item
form
aqueous suspension
Quality Segment
extent of labeling
~6 mg per mL
technique(s)
antibody protein purification: suitable
matrix activation
cyanogen bromide
matrix spacer
1 atom
capacity
~6 mg/mL binding capacity (human IgG)
storage temp.
2-8°C
General description
Application
Physical form
1 of 1
This Item | |||
|---|---|---|---|
| description aqueous suspension | description saline suspension | description aqueous suspension | description clone SPA-27, purified from hybridoma cell culture |
| form aqueous suspension | form saline suspension | form aqueous suspension | form buffered aqueous solution |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −20°C |
| Quality Level 200 | Quality Level 200 | Quality Level 300 | Quality Level 200 |
| capacity ~6 mg/mL binding capacity (human IgG) | capacity ≥15 mg/mL binding capacity (human IgG) | capacity ≥8 mg/mL binding capacity (peroxidase Type VI) | capacity - |
| extent of labeling ~6 mg per mL | extent of labeling ~2 mg per mL | extent of labeling 40-80 μmol per mL | extent of labeling - |
| matrix activation cyanogen bromide | matrix activation cyanogen bromide | matrix activation epichlorohydrin | matrix activation - |
Hazard Codes
Precautionary Statements
Hazard Classifications
Aquatic Chronic 3
Storage Class
10 - Combustible liquids
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
PPE (personal protective equipment)
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.



